MV Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65K Sell
31
-1
-3% -$109 ﹤0.01% 662
2026
Q1
$2.96K Buy
32
+1
+3% +$100 ﹤0.01% 703
2025
Q4
$3.17K Hold
31
﹤0.01% 660
2025
Q3
$1.94K Hold
31
﹤0.01% 714
2025
Q2
$1.61K Buy
31
+11
+55% +$491 ﹤0.01% 725
2025
Q1
$852 Buy
20
+1
+5% +$43 ﹤0.01% 764
2024
Q4
$581 Buy
19
+10
+111% +$281 ﹤0.01% 796
2024
Q3
$207 Sell
9
-4
-31% -$113 ﹤0.01% 892
2024
Q2
$376 Buy
13
+7
+117% +$163 ﹤0.01% 753
2024
Q1
$124 Buy
6
+5
+500% +$107 ﹤0.01% 761
2023
Q4
$28 Buy
+1
New +$26 ﹤0.01% 764

Other funds holding GH

MV Capital Management's GH Position: Q2 2026 in Review

MV Capital Management reduced its Guardant Health (GH) stake by 3.1% in Q2 2026, selling an estimated $109 and leaving 31 shares worth $4.65K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

MV Capital Management first reported a position in GH in Q4 2023 and has held it in 11 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • MV Capital Management held 31 shares of Guardant Health worth $4.65K as of Q2 2026.
  • MV Capital Management sold 1 Guardant Health share in Q2 2026, an estimated $109.
  • Guardant Health made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #662 holding.
  • MV Capital Management first reported a position in Guardant Health in Q4 2023 and has held it in 11 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.